CLINICAL_TRIALS
trial_result
· 2020-12-03
Clinical Trial Update: DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria [Phase 1]
Summary
Phase 1 trial updates for DSM265 as a chemoprophylaxis against Plasmodium falciparum malaria; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medicines for Malaria Venture | Conditions: Plasmodium Falciparum, Malaria | Phase 1 | Status: COMPLETED | Results posted: 2020-12-03